Enlitic
- Short interest
- 0.10%
- +0.09 pp 30d
- as of 21 Sept 2026
- Reported shorts
- 722.9K
- Shares on issue
- 726.798M
Enlitic (ENL) Short Interest
Enlitic (ASX:ENL) had 0.10% of shares reported as short positions as of 21 Sept 2026, representing 722,892 shares. Enlitic operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Enlitic
Enlitic is a software development company focused on leveraging artificial intelligence to improve the quality and management of medical imaging data. They provide an intelligent data framework that enhances workflows, orchestrates data, and unlocks revenue opportunities for healthcare providers by improving comprehension of information within medical imaging archives.
Company profile →Enlitic (ASX:ENL) has 0.10% of its shares on issue reported as short positions as of 21 Sept 2026, or about 722,892 shares. Over the past 30 days that figure has risen 0.09 percentage points, and over 90 days it has been broadly flat. Its highest recorded short interest was 1.93% in October 2024. ENL is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads ENL today
- Zanger BreakoutWatchScore 25rank 903 of 1893
- CAN SLIMWatchScore 10rank 1053 of 1549
- Minervini Trend TemplateNot a candidate
- Crowded-Short BreakoutNot a candidate
- Quality compoundersWatchScore 25rank 534 of 1660
Prices to 15 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
ENL fundamentals
In the half year to 30 Jun 2026, Enlitic (ASX:ENL) recorded revenue of US$1.7M and a net loss after tax of US$6.9M. Year-on-year growth: revenue +251.9% (FY). Net margin −352.3%, return on equity −177.1% (FY). Figures are in USD, the company's reporting currency; source: Company filing (extracted) and Yahoo Finance, as at 13 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest ENL news
All news- Enlitic (ASX:ENL): Ensight v2.3 Expands Healthcare Data Platform to 12 Applications - Kalkine
googlenews · 6 Oct 2026
- What Enlitic's (ASX:ENL) Ensight v2.3 release and Sectra integration mean for its platform - Kalkine
googlenews · 6 Oct 2026
- Enlitic (ASX:ENL) Releases Ensight v2.3 with 12 Applications and Sectra Integration - Kalkine
googlenews · 6 Oct 2026
Company details
website
address
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss ENL
Start a research thread or post the first pulse update